Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Staloral 300 demonstrates efficacy in phase III study for control of asthma in China

Stallergenes S.A. announces the results of a phase III clinical trial (VO55.06) conducted in China aimed at assessing the efficacy and safety of sublingual immunotherapy (Staloral(R) mites 300) in adult patients suffering from asthma triggered by house dust mites.

21 Jun 2010

Medco Health Solutions, Celesio join to help relieve financial burden on healthcare payors across Europe

Medco Health Solutions, Inc. and Celesio AG, two of the world's leading pharmacy-driven healthcare companies, today announced a joint venture with a long-term goal of improving patient health and helping to relieve the crushing financial burden on healthcare payors across Europe.

21 Jun 2010

Consumers can now access high quality health and medical information on Internet using Medgateway.com

With the vast amount of medical information on the Internet, consumers can spend long hours looking for health and medical information. Consumers can access reliable, high quality health and medical information on the Internet using Medgateway.com. Medgateway provides links to numerous health and medical web sites.

21 Jun 2010

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

NexBio, Inc. announced today the publication of a "Major Article" in the Journal of Infectious Diseases of a preclinical study showing that treatment with DAS181 (Fludase) inhibits infection with multiple human parainfluenza virus strains. DAS181 is a broad spectrum host-targeted investigational drug candidate for treatment and prevention of Influenza-Like Illness.

19 Jun 2010

Researchers study risks and consequences of cigarette smoking in people living in multiple-unit housing

In an effort to protect children from harmful tobacco smoke exposure, health and medical professionals are pushing for a ban on smoking in public housing in a report appearing in this week's New England Journal of Medicine.

18 Jun 2010

Phase 3 U.S. registration study of LODOTRA shows improvement in patients with RA

Horizon Pharma, Inc., announced today that data from the Phase 3 U.S. registration study of LODOTRA, a circadian cytokine modulator and novel modified-release, low-dose prednisone tablet, showed a statistically significant improvement in American College of Rheumatology response criteria in patients with rheumatoid arthritis.

16 Jun 2010

Physicians play stronger role in ensuring asthma patients don't waver in taking drugs: Researchers

Armed with the right information, physicians can play a stronger role in ensuring asthma patients don't waver in taking drugs proven to prevent asthma attacks, according to researchers at Henry Ford Hospital in Detroit.

16 Jun 2010

University of Montreal scientists discover free radical mechanism to viral invasion

Canadian researchers have discovered a new way the body combats respiratory viral infections. In the prestigious journal PLoS Pathogens, scientists from the University of Montreal and the University of Montreal Hospital Research Center explain how the NOX2 molecule, an enzyme that generates a burst of highly reactive oxygen derivatives (or free radicals), activates defense genes and molecules when viruses invade lung cells.

16 Jun 2010

Calistoga Pharmaceuticals presents CAL-101 PI3K inhibitor data at European Hematology Association Congress

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today presented preclinical and clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor at the 15th Congress of the European Hematology Association in Barcelona, Spain.

14 Jun 2010

Research highlights importance of CT scanning in severe asthma patients

A new study led by University of Leicester researchers at Glenfield Hospital suggests that CT scans may be the way forward for monitoring progression of severe asthma as well as checking how it is responding to treatment.

14 Jun 2010

U.S. judge approves $712.5 million settlement for 9/11 responders' health problems

"Thousands of first responders, firefighters and construction workers sickened by toxic rubble at Ground Zero could share in a settlement of up to $712.5 million announced Thursday, three months after a federal judge said a previous deal did not pay victims enough. U.S. District Court Judge Alvin Hellerstein gave preliminary approval to the settlement of a 7-year-old lawsuit against the city by nearly 10,000 people who suffered illnesses from exposure to dust and debris at the World Trade Center site after the Sept. 11 attacks."

14 Jun 2010

Gulf cleanup volunteers are putting themselves at risk of long-term health effects

With more oil from the BP spill in the Gulf washing ashore, regional communities will have a huge job of cleaning up after this vast environmental disaster. As kind-hearted volunteers participate in the effort to save both wildlife and the local environment, they will be putting themselves at risk of long-term health effects.

11 Jun 2010

Zargis Medical signs exclusive license agreement with Boston-based Stethographics

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that it has entered into an agreement with Boston-based Stethographics, Inc. providing an exclusive license to patented, FDA-cleared Stethographics lung sounds analysis technology that automatically identifies clinically significant respiratory sounds.

11 Jun 2010

$125M added to plaintiffs' compensation in WTC site operations

The WTC Captive Insurance Company, the City of New York, the contractors the City hired, their subcontractors, and attorneys for over 10,000 plaintiffs alleging injuries from the rescue, recovery and debris removal operations at the World Trade Center site operations after 9/11 today announced amendments to a March 11, 2010 settlement of those claims.

11 Jun 2010

Emerging science of epigenetics offers new insights at crossroads of genes and the environment: Article

An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.

11 Jun 2010

RXi announces new RNAi therapeutic strategy at Jefferies 2010 Global Life Sciences Conference

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the company's new focused RNAi therapeutic strategy at the Jefferies 2010 Global Life Sciences Conference.

11 Jun 2010

Sharron Davies unveils new Nottingham Respiratory BRU Clinical Trials Unit

Olympic swimmer and television personality Sharron Davies MBE was in Nottingham this week to open a new clinical trials unit that will take treatments for respiratory illnesses such as asthma from laboratory bench to bedside.

11 Jun 2010

MAP Pharmaceuticals to present new analyses from LEVADEX Phase 3 trial for acute migraine at 52nd AHS

MAP Pharmaceuticals, Inc. today announced that the Company will present new analyses from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX™ orally inhaled migraine therapy. The post hoc analyses will be presented at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California.

10 Jun 2010

Online self-management tool improves asthma patients' ability to reduce their symptoms

An online self-management tool for people with asthma has been shown to significantly improve their ability to reduce their symptoms. Researchers writing in BioMed Central's open access journal Respiratory Research tested the system in 200 adults with asthma, finding significant effects in those whose asthma was either partly controlled or uncontrolled at the beginning of the trial.

10 Jun 2010

$15 million sanctioned for replacement of school gas heaters not enough say organizations

The State Government of NSW has decided upon a $15 million replacement of nearly 100 school gas heaters especially targeting cold climate areas of NSW. The New South Wales Teachers Federation said in a statement that they will be urging the government to expand the programme to other areas replacing the unflued gas heaters in schools.

9 Jun 2010

Asthma News and Research

Further Reading

Staloral 300 demonstrates efficacy in phase III study for control of asthma in China

Medco Health Solutions, Celesio join to help relieve financial burden on healthcare payors across Europe

Consumers can now access high quality health and medical information on Internet using Medgateway.com

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

Researchers study risks and consequences of cigarette smoking in people living in multiple-unit housing

Phase 3 U.S. registration study of LODOTRA shows improvement in patients with RA

Physicians play stronger role in ensuring asthma patients don't waver in taking drugs: Researchers

University of Montreal scientists discover free radical mechanism to viral invasion

Calistoga Pharmaceuticals presents CAL-101 PI3K inhibitor data at European Hematology Association Congress

Research highlights importance of CT scanning in severe asthma patients

U.S. judge approves $712.5 million settlement for 9/11 responders' health problems

Gulf cleanup volunteers are putting themselves at risk of long-term health effects

Zargis Medical signs exclusive license agreement with Boston-based Stethographics

$125M added to plaintiffs' compensation in WTC site operations

Emerging science of epigenetics offers new insights at crossroads of genes and the environment: Article

RXi announces new RNAi therapeutic strategy at Jefferies 2010 Global Life Sciences Conference

Sharron Davies unveils new Nottingham Respiratory BRU Clinical Trials Unit

MAP Pharmaceuticals to present new analyses from LEVADEX Phase 3 trial for acute migraine at 52nd AHS

Online self-management tool improves asthma patients' ability to reduce their symptoms

$15 million sanctioned for replacement of school gas heaters not enough say organizations

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News